PBM reform is here. What do new transparency and fiduciary rules mean for the industry? Federal legislation, new state laws and proposed reforms are placing pharmacy benefit managers under growing scrutiny.
Managed Healthcare Executive® partnered with Drug Topics® on a timely webinar, PBMs, Transparency and Fiduciary Responsibility, examining how emerging PBM transparency requirements, fiduciary responsibilities and policy reforms could reshape relationships among payers, pharmacies and PBMs.
Watch the recorded discussion now to hear expert perspectives on the evolving regulatory landscape and what these policy changes may mean for managed care strategy and pharmacy benefit operations.
In this discussion, Chad Hatfield, Pharm.D., M.H.A., BCPS, shares his perspective on the evolving role of pharmacy services and the value of collaboration across health care.
Five transcranial magnetic stimulation sessions in one day improved processing speed in adults with schizophrenia, which holds promise for future treatment possibilities, according to researcher Heather Burrell Ward, M.D.